Articles related to Endocrinology, Diabetes, Metabolism

Analysis of 285,680 patients shows a 1.03-1.38% reduction in cumulative mortality with rosuvastatin compared to atorvastatin, alongside varying risks for cardiovascular events, liver outcomes, and diabetes.

Current evidence indicates that while digestive and energy improvements may manifest within one week, longer-term benefits require extended supplementation periods and careful monitoring of iodine levels.

Clinical research demonstrates that erythritol consumption increases blood levels by more than 1,000 times and enhances platelet responsiveness in healthy volunteers, potentially elevating cardiovascular risk in susceptible populations.

Clinical research indicates that consistent nut consumption correlates with reduced cardiovascular mortality, with each variety offering distinct nutritional advantages for patient-specific needs.

Fresh pineapple demonstrates a moderate glycemic index of 51-66, making it a viable fruit option for diabetic patients when consumed with appropriate portion control and protein pairing strategies.

The combination of structured lifestyle interventions with targeted pharmacotherapy demonstrates significant potential for achieving substantial weight loss in patients with type 2 diabetes.